Advertisement

Topics

VALNEVA Reports Strong Operational Performance for the First Nine Months of 2017

02:00 EST 9 Nov 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Valneva Reports Strong Operational Performance for the First Nine Months of 2017 Strong financial performance for first nine months of 2017 and full year outlook leads to upward revision of EBITDA guidance Total revenues of €79.8 million in t...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "VALNEVA Reports Strong Operational Performance for the First Nine Months of 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...